Status: Not yet recruiting
Prognostic Value of (DHODH) Expression in (HGSOC): A Comparative Study Between Neoadjuvant and Adjuvant Chemotherapy Settings
* To compare DHODH protein expression in HGSC tissues from patients undergoing Primary Debulking Surgery (PDS - Chemo-naive) versus Interval Debulking Surgery (IDS - Post-NACT). * To evaluate the association between DHODH expression and the degree of chemotherapy response (using the Chemotherapy Response Score - CRS for NACT cases). * To determine the prognostic value of DHODH expression in predicting Platinum-Free Interval (PFI) ,Progression -Free Survival (PFS) and Overall Survival (OS) across both groups.
Participants needed: 72
Trial details
Biological sex: FemaleType: ObservationalSponsor: Heba Ahmed MohamedUpdated: Jan 26, 2026Locations: 1
Eligibility criteria
Histologically confirmed high-grade serous ovarian carcinoma [+3]
Non-serous histological subtypes [+3]